Administration of Linoleoylethanolamide Reduced Weight Gain, Dyslipidemia, and Inflammation Associated with High-Fat-Diet-Induced Obesity
Rubén Tovar(Hospital Regional Universitario de Málaga), Juan Decara(Andalusian Centre for Nanomedicine and Biotechnology)
Cited by 18
Related Papers
Peroxisome Proliferator-Activated Receptors: Experimental Targeting for the Treatment of Inflammatory Bowel Diseases
|Frontiers in Pharmacology|2020|192
Palmitoleoylethanolamide Is an Efficient Anti-Obesity Endogenous Compound: Comparison with Oleylethanolamide in Diet-Induced Obesity
|Nutrients|2021|24
Treatment with a novel oleic-acid–dihydroxyamphetamine conjugation ameliorates non-alcoholic fatty liver disease in obese Zucker rats
|Disease Models & Mechanisms|2015|22